Viridian Therapeutics, Inc.\DE (VRDN) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US92790C1045
Viridian Therapeutics, Inc.\DE financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 70.85 m USD |
| Operating income | -363.40 m USD |
| EBIT | -365.05 m USD |
| Net income | -342.60 m USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Viridian Therapeutics, Inc.\DE
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered, and Elegrobart, a low-volume, infrequently dosed subcutaneous IGF-1R. The company also develops an anti-thyroid-stimulating hormone receptor (TSHR) candidate for the treatment of Graves' disease and TED. Its portfolio of engineered inhibitors of the neonatal Fc receptor (FcFn) includes VRDN-006, a highly selective Fc fragment, and VRDN-008, a half-life extended bispecific FcRn inhibitor comprising an GC fragment and an albumin-binding domain designed to prolong IGG suppression. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was incorporated in 2010 and is headquartered in Waltham, Massachusetts.
More stocks
- Pt Pradiksi Gunatama Tbk (PGUN.JK)
- Merdeka Copper Gold PT (MDKA.JK)
- Caiss Regio Credi Agric Mutuel Paris Idf (CAF.PA)
- Guangzhou Zhujiang Brewery Co Ltd (002461.SZ)
- COL Digital Publishing Group Co Ltd (300364.SZ)
- FULLER H B CO (FUL)
- REN Redes Energeticas Nacionais SGPS SA (RENE.LS)
- MARA Holdings, Inc. (MARA)
- Shenzhen Hirisun Technology Inc (300277.SZ)
- NEXTDC Ltd (NXT.AX)
- Winner Medical Co Ltd (300888.SZ)
- Universal Microwave Technology (3491.TWO)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.